Nevada § 439.5272 Specifications of designated department governing reporting information to and accessing information

Nevada Statutes

§ 439.5272 — Specifications of designated department governing reporting information to and accessing information

Nevada § 439.5272

Title 40PUBLIC HEALTH AND SAFETY

Ch. 439Administration

REPORTING AND ANALYZING INFORMATION ON NEURODEGENERATIVE DISEASES

This text of Nevada § 439.5272 (Specifications of designated department governing reporting information to and accessing information) is published on Counsel Stack Legal Research, covering Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Nev. Rev. Stat. § 439.5272 (2026).

Text

If a system for the reporting of information on neurodegenerative diseases is established pursuant to NRS 439.5268, the designated department shall, in consultation with the Chief Medical Officer:

1.Prescribe the neurodegenerative diseases for which information may be reported in accordance with NRS 439.5274 , which may include, without limitation, Parkinson’s disease, Parkinsonisms, multiple sclerosis and Alzheimer’s disease;

2.Prescribe the form and manner for reporting information on cases of neurodegenerative diseases and the information that may be included in each report; and

3.Establish protocol for allowing access to and preserving the confidentiality of the records of patients needed for research into neurodegenerative diseases.

Free access — add to your briefcase to read the full text and ask questions with AI

If a system for the reporting of information on neurodegenerative diseases is established pursuant to NRS 439.5268, the designated department shall, in consultation with the Chief Medical Officer:
1. Prescribe the neurodegenerative diseases for which information may be reported in accordance with NRS 439.5274 , which may include, without limitation, Parkinson’s disease, Parkinsonisms, multiple sclerosis and Alzheimer’s disease;
2. Prescribe the form and manner for reporting information on cases of neurodegenerative diseases and the information that may be included in each report; and
3. Establish protocol for allowing access to and preserving the confidentiality of the records of patients needed for research into neurodegenerative diseases.